| Summary |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Reference and Education > Science > Democracy and Scientific Technique |
|
Summary - Democracy and Scientific Technique
The word ‘democracy’ has become ambiguous. East of the Elbe it means ‘military dictatorship According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product of a minority enforced by arbitrary police power’. West of the Elbe its meaning is less defi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ite, but broadly speaking it means ‘even distribution of ultimate political power among all lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. adults except lunatics, criminals, and peers’. This is not a precise definition, because of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he world ‘ultimate’. Suppose the British Constitution were to be changed in only one respect d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro that General Elections should occur once in thirty years instead of once in five. This woul ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d so much diminish the dependence of parliament on public opinion that the resulting system easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ould hardly be called a democracy. Many Socialists would add economic to political power, as nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically what demands even distribution in a essence of the matter is approach to equality of power, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and it is obvious that democracy is a matter of degree. When people think of democracy, the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi generally couple with it a considerable measure of liberty for individuals and groups. Reli ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a gious persecution, for instance, would be excluded in imagination, although it is entirely c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mpatible with democracy as defined a moment ago. I incline to think that ‘liberty’, as the w cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ord was understood in the eighteenth and nineteenth centuries, is no longer quite the right tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen oncepts; I should prefer to substitute ‘opportunity for initiative’. And my reason for sugge t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ting this change is the character of a scientific society. It cannot be denied that democra ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cy no longer inspires the same enthusiasm as it inspired in Rousseau and the men of the Fren y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products h Revolution. This is, of course, mainly because it has been achieved. Advocates of a reform . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de always overstate their case, so that their converts expect the reform to bring the millenni elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip m. When it fails to do so there is disappointment, even if very solid advantages are secured tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bad Credit Habits 'Learned From Elders' Top Trading Disasters and How to Avoid Them - Part I
|